Search - tctmd.com

Displaying 161 - 180 of 414

Sort: Relevancy | Date

Smartphone Heart Rate-Monitoring App Can Accurately Assess Radial Artery Patency

News Daily News

Smartphone Heart Rate-Monitoring App Can Accurately Assess Ulnar Artery Patency

Todd Neale

April 03, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

Shelley Wood

March 01, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Daily News

PCI via Ulnar Artery Equally as Safe and Effective as Transradial Approach

Michael O'Riordan

February 09, 2018

News Conference News ISET 2018

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

Caitlin E. Cox

February 08, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Daily News

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

Todd Neale

December 08, 2017

News Conference News AHA 2017

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Yael L. Maxwell

November 12, 2017

Presentation TCT 2017

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Presenter: William A. Gray, Thomas Zeller

November 01, 2017

Presentation TCT 2017

Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents

Presenter: D. Christopher Metzger, Ido Weinberg

October 31, 2017

News Daily News

Endothelial Dysfunction Observed Following Transradial Catheterization, Meta-analysis Suggests

Michael O'Riordan

September 22, 2017

News Industry News

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

September 19, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Conference News ESC 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

Todd Neale

August 29, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 26, 2017

News Daily News

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Yael L. Maxwell

June 30, 2017

News Industry News

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

June 22, 2017

Advertisement

Smartphone Heart Rate-Monitoring App Can Accurately Assess Ulnar Artery Patency

TCTMD’s Top 10 Most Popular Stories for February 2018

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

PCI via Ulnar Artery Equally as Safe and Effective as Transradial Approach

MIMICS-2 at 1 Year: 3-D Stent Meets Safety and Effectiveness Goals

SELUTION™ First-in-Man Study Achieves Primary Endpoint

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Optimal Technique: Radial vs Femoral Access, and Optimizing Patency With Covered vs Bare Metal Stents

Endothelial Dysfunction Observed Following Transradial Catheterization, Meta-analysis Suggests

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

P2Y12 Inhibitor Pretreatment Questioned in STEMI

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content